exo-IWR-1

CAS No. 1127442-87-8

exo-IWR-1( —— )

Catalog No. M23321 CAS No. 1127442-87-8

exo-IWR-1 is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1 (HY-12238).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 72 In Stock
25MG 160 In Stock
50MG 276 In Stock
100MG 452 In Stock
500MG 981 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    exo-IWR-1
  • Note
    Research use only, not for human use.
  • Brief Description
    exo-IWR-1 is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1 (HY-12238).
  • Description
    exo-IWR-1 is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1 (HY-12238). IWR-1 is a tankyrase inhibitor which inhibits Wnt/β-catenin signaling pathway.
  • In Vitro
    exo-IWR-1 (10 μM) does not influence the number of 293T cells infected with bunyaviruses.Exo-IWR-1 had no effect on RVFV MP12-GFP infection when cells were either pretreated or treated 1 hpi.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    wnt
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1127442-87-8
  • Formula Weight
    409.44
  • Molecular Formula
    C25H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2C(=O)N(C3=O)C4=CC=C(C=C4)C(=O)NC5=CC=CC6=C5N=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JW 67

    JW 67 is an inhibitor of canonical Wnt pathway signaling. JW 67 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.

  • Isx 9

    ISX9 was necessary to activate neuron-specific genes as neurogenesis inducer.

  • Foxy-5

    Foxy-5 is a novel Wnt-5A mimicking hexapeptide that inhibits breast cancer metastasis in vivo by targeting cell motility.